Here are a few of the most interesting Astellas statistics and facts I was able to dig up. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
Please note that some of these numbers are easier to find than others. A few of these Astellas stats come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%
- Astellas Website: www.astellas.com
- Year Astellas was Founded: 2005
- Astellas Headquarters: Tokyo, Japan
- Astellas CEO: Kenji Yasukawa
Number of Astellas employees:
Last updated 3/1/20
Astellas revenue (annual):
- FY 2019: 1,300,843 million yen
- FY 2018: 1,306,348 million yen
- FY 2017: 1,300,316 million yen
- FY 2016: 1,311,665 million yen
- FY 2015: 1,372,706 million yen
Astellas gross profit (annual):
Get the Industry Report
This full report is available in an annual industry report. Some of the data in industry reports include:
- Company Quick Facts
- Employee Counts
- Income and Revenue Totals
- Etc.- all in one place
I try to go through each and every stat regularly and update as much as possible, but we all know that some stats are easier to track down than others. As always, every stat is linked to its original source and has the source date listed.
To get your copy of the report, click on the button below to purchase it.
Report 1: Biopharma Industry Report ( Abbott, Abbvie, Allergan, Amgen, Astellas, AstraZeneca, Bayer, Biogen, Bristol-Myers Squibb, Eli Lilly, Gilead, GlaxoSmithKline, Illumina, Johnson & Johnson, Merck, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche, Sanofi, Stryker, Takeda, Vertex and Zoetis).